Maria L. Formica
Cordoba, X, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cooperative supramolecular integration of QS-21 into polymeric micelles as a tunable nanoadjuvant platform for subunit vaccines.
Journal: RSC advances
Published: March 05, 2026
Development of hyaluronic acid-based nanocomposite eye drops: A synergistic platform for enhanced ocular delivery of acetazolamide.
Journal: International journal of pharmaceutics: X
Published: February 04, 2026
Triamcinolone-loaded nanocarriers: a novel strategy to mitigate cognitive and emotional sequelae induced by traumatic brain injury via modulation of oxidative stress.
Journal: Frontiers in behavioral neuroscience
Published: May 30, 2025
Doxycycline inhibits MMP-2 retinal activity and modulates the angiogenic process in vitro and in vivo.
Journal: Frontiers in cell and developmental biology
Published: January 15, 2025
Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.
Journal: International journal of pharmaceutics
Published: January 13, 2025
In vivo pharmacokinetic study and PBPK modeling: Comparison between 3D-printed nanocrystals and solid dispersions.
Journal: International journal of pharmaceutics
Published: October 22, 2024
Nanotechnological approaches to improve corticosteroids ocular therapy.
Journal: Methods (San Diego, Calif.)
Published: August 09, 2024
Design of a pilot plant-type pharmaceutical reactor to address the problem of interchangeability of generic semisolid formulations.
Journal: Drug development and industrial pharmacy
Published: October 26, 2023
Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration.
Journal: Pharmaceutics
Published: January 04, 2023
Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology.
Journal: Pharmacology research & perspectives
Published: December 01, 2020
Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody - Bevacizumab - and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies.
Journal: Materials science & engineering. C, Materials for biological applications
Published: June 21, 2020
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Journal: International journal of pharmaceutics
Published: June 14, 2019
Last Updated: 09/26/2026